DesignationBadgeThe Pheo Para Alliance, a patient advocacy organization that supports patients with pheochromocytoma (pheo) and paraganglioma (para), which are rare neuroendocrine tumors that can be benign or malignant, has designated The Ohio State University Wexner Medical Center as a Center of Excellence for treating and studying these and related genetic illnesses. The Center of Excellence Program recognizes institutions worldwide for providing quality multidisciplinary care for patients with these diseases and for participating in research on the underlying molecular causes. A team of physicians from several specialties is involved in neuroendocrine patient care, including those from the Department of Surgery, Department of Otolaryngology – Head and Neck Surgery and the divisions of Endocrinology, Medical Oncology and Genetics in the Department of Internal Medicine, as well as the Comprehensive Adrenal Program (CAP), a new formally organized multidisciplinary team that serves patients from around the world. Because patients with such a rare disease often travel to Columbus from a far distance, the Ohio State Wexner Medical Center’s Destination Medicine Global Health Care program works with families to coordinate travel and in-town accommodations and provide any necessary translation to eliminate any distance or language barriers to treatment. To learn more about CAP, visit medicine.osu.edu/departments/surgery/news/new-comprehensive-adrenal-program.